Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citrafleet vs MoviPrep for Colonoscopy in Ulcerative Colitis
NCT03581149Phase 4Unknown
- Sponsor
- American University of Beirut Medical Center
- Start
- Mar 2018
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of sodium picosulfate + magnesium oxide + citric acid (2 arms), sponsored by American University of Beirut Medical Center. Primary endpoint: Tolerability of the preparation at 1 year. Status: unknown.
02
Drugs
sodium picosulfate + magnesium oxide + citric acid
Beyond the preview
Go deeper on NCT03581149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03581149.